Mario Martins

Dr. Mario Martins

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2021 in European Journal of Histochemistry
Verified
Journal Article
Open access
PDF file
MQMichael Williams Leal Quirino
Michael Williams Leal Quirino
MPMichelly Cristiny Pereira
Michelly Cristiny Pereira
MSMaria de Fátima Deodato de Souza
Maria de Fátima Deodato de Souza
IPIvan da Rocha Pitta
Ivan da Rocha Pitta
AFAntônio Felix Da Silva Filho
Antônio Felix Da Silva Filho
MRMoacyr Rêgo
Moacyr Rêgo
The sialic acid-binding immunoglobulin-type lectin Siglec-15 is a promising target to cancer immunotherapy in several tumor types. The present study aimed to investigate Siglec-15 expression in gastric cancer (GC) patient tissue and to evaluate its clinical value. Siglec-15 expression was evaluated by immunohistochemistry with 71 patients. Siglec-15 staining was observed in tumor cells of 53 (74.64%) patients, with significant association with histologic classification and angiolymphatic invasion (p<0.05). Immunohistochemistry analysis also detected Siglec-15 in tumor-associated stroma cells (macrophages/myeloid cells). There was no significant association with outcomes parameters. Siglec-15 expression in well differentiated histological GC tissues and in the tumor microenvironment are potential targets to be further investigated as a novel prognostic factor for GC.

12 March 2018 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
MMMario Martins
Mario Martins
RSRogério L. D. Santos
Rogério L. D. Santos
KJKleber D. N. Jatahy
Kleber D. N. Jatahy
MMMarina C. D. Matta
Marina C. D. Matta
TBThales P. Batista
Thales P. Batista
LTLeuridan C. Torres
Leuridan C. Torres

19 December 2019 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
PLPetrus M. A. Lima
Petrus M. A. Lima
LTLeuridan Cavalcante Torres
Leuridan Cavalcante Torres
MMMario Martins
Mario Martins
MMMarina C. da Matta
Marina C. da Matta
JLJurema T. O. Lima
Jurema T. O. Lima
NFNora M. Forones
Nora M. Forones

29 September 2022 in European Journal of Histochemistry
Verified
Journal Article
Open access
PDF file
MQMichael W.L. Quirino
Michael W.L. Quirino
AAAmanda P.B. Albuquerque
Amanda P.B. Albuquerque
MSMaria F.D. De Souza
Maria F.D. De Souza
AFAntônio F. Da Silva Filho
Antônio F. Da Silva Filho
MMMario Martins
Mario Martins
MRMoacyr Rêgo
Moacyr Rêgo
Gastric cancer (GC) is one of the leading causes of cancer-related deaths worldwide. Despite progress in the last decades, there are still no reliable biomarkers for the diagnosis of and prognosis for GC. Aberrant sialylation is a widespread critical event in the development of GC. Neuraminidases (Neu) and sialyltransferases (STs) regulate the ablation and addition of sialic acid during glycoconjugates biosynthesis, and they are a considerable source of biomarkers in various cancers. This study retrospectively characterized Neu3 and ST3Gal3 expression by immunohistochemistry in 71 paraffin-embedded GC tissue specimens and analyzed the relationship between their expression and the clinicopathological parameters. Neu3 expression was markedly increased in GC tissues compared with non-tumoral tissues (p<0.0001). Intratumoral ST3Gal3 staining was significantly associated with intestinal subtype (p=0.0042) and was negatively associated with angiolymphatic invasion (p=0.0002) and higher histological grade G3 (p=0.0066). Multivariate analysis revealed that ST3Gal3 positivity is able to predict Lauren's classification. No associations were found between Neu3 staining and clinical parameters. The in silico analysis of mRNA expression in GC validation cohorts corroborates the significant ST3Gal3 association with higher histological grade observed in our study. These findings suggest that ST3Gal3 expression may be an indicator for aggressiveness of primary GC.

9 August 2019 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
MMMario Martins
Mario Martins
RARenata Santos Almeida
Renata Santos Almeida
NLNorma Lucena-Silva
Norma Lucena-Silva
CCCláudia Malheiros Coutinho-Camilo
Cláudia Malheiros Coutinho-Camilo
ITIsrael Torjal
Israel Torjal
MBMaria Dirlei F. S. Begnami
Maria Dirlei F. S. Begnami

24 July 2024 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
GFGuilherme Vieira de Mendonça Filho
Guilherme Vieira de Mendonça Filho
GCGuilherme Jorge Costa
Guilherme Jorge Costa
MMMario Martins
Mario Martins
LTLeuridan C. Torres
Leuridan C. Torres